Results 291 to 295 of about 218,137 (295)

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

Neuro-Oncology, 2015
Anna S Berghoff, Barbara Kiesel, Georg Widhalm   +2 more
exaly  

Programmed death ligand 1 testing in non–small cell lung carcinoma cytology cell block and aspirate smear preparations

Cancer Cytopathology, 2018
Wei-Lien Wang, Yun Gong, Jun Zhao
exaly  

Assessment of programmed death‐ligand 1 expression and tumor‐associated immune cells in pediatric cancer tissues

Cancer, 2017
Robbie G Majzner, Jason S Simon, Daniel Martinez   +2 more
exaly  

A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial

Journal of Thoracic Oncology, 2019
Jean-Louis Pujol, Laurent Greillier, Florian Guisier   +2 more
exaly  

Clinical Significance of Programmed Death-1 Ligand-1 Expression in Patients with Non-Small Cell Lung Cancer: A 5-year-follow-up Study

Tumori, 2012
exaly